fashion -WSS

fashion

author：explore 2025-10-01 10:38:23 - browse：53983

Biogen, a biotech giant plagued by years of boardroom strife, said late Monday that the longtime and polarizing director Alex Denner would step down from its board, sending a signal to investors that the company’s fractious recent history might be coming to a close.

What Biogen didn’t disclose is that its nominee to replace Denner on the board, Susan Langer, is Denner’s live-in romantic partner and the mother of his child, born in November, according to court records obtained by STAT. Denner is in the middle of a protracted divorce from his wife of nearly 25 years, with whom he has two teenage sons — a bitter legal fight in which his extramarital relationship with Langer is a contentious issue, according to the records.

Biogen spokesperson Jack Cox said the company knew about the relationship between Denner and Langer. He also said that Denner recommended Langer to Biogen’s board — he said he incorrectly stated at first that Denner nominated her — but declined to comment on the company’s vetting process and whether it planned to disclose the relationship to shareholders before they vote on Langer’s candidacy later this month. Biogen also omitted mention of the relationship from Langer’s biography in a Securities and Exchange Commission filing Tuesday morning.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： Roivant's CEO is a star, but biotech's black hole persists

entertainment

WSS

How AI can help patients find reliable information about doctors

First Opinion Podcast: Long Covid needs a new approach

CEOs share strategies for surviving biotech slump

Health tech investors get more selective as pandemic boom fades

Pharmacists can make shortage drugs, but at what cost?

How climate

hotspot

fashion

hotspot

Hepatitis C has a cure — but many Americans still lack access to it

STAT Summit: How researchers deal with rejection

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Roche acquires Telavant from Roivant, adding experimental IBD treatment

How one medical school became remarkably diverse

Why a market frenzy over new weight loss drugs defies logic

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Will Ozempic

Supreme Court strikes down use of affirmative action

The EU Joint Clinical Assessment needs to live up to its promise

entertainment

Health tech investors get more selective as pandemic boom fades

The EU Joint Clinical Assessment needs to live up to its promise

Roche acquires Telavant from Roivant, adding experimental IBD treatment

STAT Summit: How researchers deal with rejection

Questions loom on AstraZeneca cancer drug as safety concerns ebb

STAT Summit: Ending the crisis of Black deaths in the U.S.

knowledge

entertainment

entertainment

knowledge